David Benjamin Turitz Cox, MD PhD
David Benjamin Turitz Cox, MD PhD
Resident Physician, Stanford Health Care
Verified email at stanford.edu
Title
Cited by
Cited by
Year
Multiplex genome engineering using CRISPR/Cas systems
L Cong, FA Ran, D Cox, S Lin, R Barretto, N Habib, PD Hsu, X Wu, ...
Science, 1231143, 2013
127922013
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
W Jiang, D Bikard, D Cox, F Zhang, LA Marraffini
Nature biotechnology 31 (3), 233, 2013
22072013
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
OO Abudayyeh, JS Gootenberg, S Konermann, J Joung, IM Slaymaker, ...
Science 353 (6299), aaf5573, 2016
11062016
Crispr Evolution: C2c2 is a single-component programmable Rna-guided Rna-targeting Crispr effector
OO Abudayyeh, JS Gootenberg, S Konermann, J Joung, IM Slaymaker, ...
Science 353 (6299), 557, 2016
11062016
Therapeutic genome editing: prospects and challenges
DBT Cox, RJ Platt, F Zhang
Nature medicine 21 (2), 121, 2015
10252015
RNA targeting with CRISPR–Cas13
OO Abudayyeh, JS Gootenberg, P Essletzbichler, S Han, J Joung, ...
Nature 550 (7675), 280, 2017
8732017
RNA editing with CRISPR-Cas13
DBT Cox, JS Gootenberg, OO Abudayyeh, B Franklin, MJ Kellner, J Joung, ...
Science 358 (6366), 1019-1027, 2017
8602017
Diversity and evolution of class 2 CRISPR–Cas systems
S Shmakov, A Smargon, D Scott, D Cox, N Pyzocha, W Yan, ...
Nature Reviews Microbiology 15 (3), 169, 2017
5882017
Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28
AA Smargon, DBT Cox, NK Pyzocha, K Zheng, IM Slaymaker, ...
Molecular cell 65 (4), 618-630. e7, 2017
3312017
Engineered Cpf1 variants with altered PAM specificities
L Gao, DBT Cox, WX Yan, JC Manteiga, MW Schneider, T Yamano, ...
Nature biotechnology 35 (8), 789, 2017
2652017
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
V Ramanan, A Shlomai, DBT Cox, RE Schwartz, E Michailidis, A Bhatta, ...
Scientific reports 5, 10833, 2015
2312015
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, DBT Cox, L Marraffini, DO Bikard, W Jiang, NE Sanjana
US Patent 9,822,372, 2017
1162017
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, DBT Cox, L Marraffini, DO Bikard, W Jiang, NE Sanjana
US Patent App. 15/887,377, 2018
722018
Engineering and optimising deaminase fusions for genome editing
L Yang, AW Briggs, WL Chew, P Mali, M Guell, J Aach, DB Goodman, ...
Nature communications 7, 13330, 2016
662016
CRISPR-assisted editing of bacterial genomes
W Jiang, D Bikard, D Cox, F Zhang, LA Marraffini
Nature biotechnology 31 (3), 233, 2013
642013
Engineered Cpf1 Enzymes with Altered PAM Specificities
L Gao, DBT Cox, WX Yan, J Manteiga, M Schneider, T Yamano, ...
bioRxiv, 091611, 2016
102016
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for genome editing
L Cong, DBT Cox, M Heidenreich, RJ Platt, L Swiech, F Zhang
US Patent App. 15/179,799, 2016
52016
DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF CRISPR SYSTEMS AND COMPOSITIONS FOR GENOME EDITING AS TO HEMATOPOIETIC STEM CELLS (HSCs)
DBT Cox, JE Dahlman, F Zhang
US Patent App. 15/619,737, 2017
22017
Corrigendum: Engineering and optimising deaminase fusions for genome editing
L Yang, AW Briggs, WL Chew, P Mali, M Guell, J Aach, DB Goodman, ...
Nature communications 8, 16169, 2017
22017
Type vi-b crispr enzymes and systems
F Zhang, A SMARGON, N PYZOCHA, DBT Cox, ES Lander
22017
The system can't perform the operation now. Try again later.
Articles 1–20